For instance, Kojima et al. have developed an emerging technique to delivery therapeutic catalase mRNA into the cytosol of nerve cell, which cannot only attenuate localized neuroinflammation but also rescue neuroinflammation in the model of Parkinson's disease. Here, CAT is linked to Parkinson disease.